Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Examining the Effectiveness of DermGEN™ Versus Standard of Care in the Treatment of Diabetic Foot Ulcers in First Nations People Living in Northwestern Ontario Communities

NCT05251480 is registered in ClinicalTrials.gov with DeCell Technologies Inc. as lead sponsor.

NCT NCT05251480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05251480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Examining the Effectiveness of DermGEN™ Versus Standard of Care in the Treatment of Diabetic Foot Ulcers in First Nations People Living in Northwestern Ontario Communities
Lead sponsor
DeCell Technologies Inc.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 30, 2024
Completion date
December 1, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, diabetic foot ulcer, non-healing wound, tissue injury, ulcer foot, ulcer healing, wound of skin, wound; foot